Medical Evaluation of Licensed Personnel for Nuclear Power Plants, 60197-60199 [2014-23717]
Download as PDF
Federal Register / Vol. 79, No. 193 / Monday, October 6, 2014 / Notices
60197
Day
Event/Activity
A ..................
If access granted: Issuance of presiding officer or other designated officer decision on motion for protective order for access to
sensitive information (including schedule for providing access and submission of contentions) or decision reversing a final adverse determination by the NRC staff.
Deadline for filing executed Non-Disclosure Affidavits. Access provided to SUNSI consistent with decision issuing the protective
order.
Deadline for submission of contentions whose development depends upon access to SUNSI. However, if more than 25 days remain between the petitioner’s receipt of (or access to) the information and the deadline for filing all other contentions (as established in the notice of hearing or opportunity for hearing), the petitioner may file its SUNSI contentions by that later deadline.
(Contention receipt +25) Answers to contentions whose development depends upon access to SUNSI.
(Answer receipt +7) Petitioner/Intervenor reply to answers.
Decision on contention admission.
A + 3 ...........
A + 23 .........
A + 48 .........
A + 55 .........
>A + 55 .......
[FR Doc. 2014–23800 Filed 10–3–14; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[Docket No. 50–255; NRC–2014–0216]
Entergy Nuclear Operations, Inc.;
Palisades Nuclear Plant
Nuclear Regulatory
Commission.
ACTION: 10 CFR 2.206 request; receipt.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is giving notice that
by petition dated March 5, 2014, as
supplemented by email dated May 21,
2014, Michael Mulligan (the petitioner)
has requested that the NRC take
enforcement action against Entergy
Nuclear Operations, Inc., due to recent
plant events and equipment failures at
Palisades Nuclear Plant (PNP). The
petitioner’s requests are included in the
SUPPLEMENTARY INFORMATION section of
this document.
ADDRESSES: Please refer to Docket ID
NRC–2014–0216 when contacting the
NRC about the availability of
information regarding this document.
You may obtain publicly-available
information related to this document
using any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2014–0216. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–287–3422;
email: Carol.Gallagher@nrc.gov.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publicly
available documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:17 Oct 03, 2014
Jkt 235001
email to pdr.resource@nrc.gov. The
ADAMS accession number for each
document referenced in this document
(if that document is available in
ADAMS) is provided the first time that
a document is referenced.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that by petition dated
March 5, 2014 (ADAMS Accession No.
ML14071A006), as supplemented by
email dated May 21, 2014 (ADAMS
Accession No. ML14142A101), and the
petitioner’s addresses to the Petition
Review Board dated April 8 and
September 3, 2014 (ADAMS Accession
Nos. ML14143A212 and ML14259A135,
respectively), the petitioner, has asked
the NRC to take enforcement action
against Entergy Nuclear Operations,
Inc., due to recent plant events and
equipment failures at PNP. The
petitioner was particularly concerned
with primary coolant pump (PCP)
impeller pieces breaking off and lodging
in the reactor vessel.
The petitioner requests the following
actions:
• Require PNP to open every PCP for
inspection and clear up all flaws.
• Require PNP to replace the PCPs
with a design for their intended duty.
• An Office of Inspector General
(OIG) inspection on why there are
different analysis criteria for similar
PCP events between the NRC regions.
• A ten million dollar fine for these
events.
• Intensify NRC monitoring of PNP,
and return them to yellow or red status.
As the basis for the request, the
petitioner stated, in part, the following:
• The petitioner cited other recent
plant events and equipment failures,
such as leakage from the safety injection
refueling water tank, and flaws in the
control rod drive mechanisms.
• The petitioner asserted the licensee
and the NRC staff used non-conservative
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
engineering judgment during the
evaluation of the lodged PCP impeller
piece and during the operability
evaluation of the existing PCP impellers.
• The petitioner asserts that the NRC
staff was not being aggressive in
resolving plant equipment issues, not
resolving PCP equipment issues
uniformly across the NRC regions, and
accommodating the nuclear industry.
The request is being treated pursuant
to § 2.206 of Title 10 of the Code of
Federal Regulations (10 CFR), and has
been referred to the Director of the
Office of Nuclear Reactor Regulation
(NRR). In accordance with 10 CFR
2.206, the NRC will take appropriate
action on this petition within a
reasonable period of time. The
petitioner met with the NRR’s Petition
Review Board on April 8 and September
3, 2014, to discuss the petition. The
Petition Review Board considered the
results of that discussion in its
determination of the petitioner’s request
for immediate action and in the
establishment of the schedule for the
review of the petition.
Dated at Rockville, Maryland, this 25th day
of September 2014.
For The Nuclear Regulatory Commission.
Daniel H. Dorman,
Acting Director, Office of Nuclear Reactor
Regulation.
[FR Doc. 2014–23802 Filed 10–3–14; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2014–0093]
Medical Evaluation of Licensed
Personnel for Nuclear Power Plants
Nuclear Regulatory
Commission.
ACTION: Regulatory guide; issuance.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is issuing revision 4
to Regulatory Guide (RG) 1.134,
‘‘Medical Assessment of Licensed
SUMMARY:
E:\FR\FM\06OCN1.SGM
06OCN1
mstockstill on DSK4VPTVN1PROD with NOTICES
60198
Federal Register / Vol. 79, No. 193 / Monday, October 6, 2014 / Notices
Operators or Applicants for Operator
Licenses at Nuclear Power Plants.’’ The
NRC is updating RG 1.134 based upon
the regulatory experience gained since
the previous revision was issued and to
endorse the 2013 revision to the
underlying consensus standard,
American National Standard Institute/
American Nuclear Society (ANSI/ANS)
Standard 3.4, ‘‘Medical Certification and
Monitoring of Personnel Requiring
Licenses for Nuclear Power Plants.’’ The
guide helps to ensure that medical
certifications (and related medical
evidence) are sufficient to meet the
NRC’s nuclear power reactor operator
licensing requirements.
ADDRESSES: Please refer to Docket ID
NRC–2014–0093 when contacting the
NRC about the availability of
information regarding this document.
You may obtain publicly-available
information related to this document
using any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2014–0093. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–287–3422;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual(s) listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may access publicly
available documents online in the NRC
Library at https://www.nrc.gov/readingrm/adams.html. To begin the search,
select ‘‘ADAMS Public Documents’’ and
then select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
ADAMS accession number for each
document referenced in this notice (if
that document is available in ADAMS)
is provided the first time that a
document is referenced. Revision 4 of
Regulatory Guide 1.134 is available in
ADAMS under Accession No.
ML14189A385. The regulatory analysis
may be found in ADAMS under
Accession No. ML13352A279.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
Regulatory guides are not
copyrighted, and NRC approval is not
required to reproduce them.
FOR FURTHER INFORMATION CONTACT:
Lawrence Vick, Office of Nuclear
Reactor Regulation, telephone: 301–
VerDate Sep<11>2014
17:17 Oct 03, 2014
Jkt 235001
415–3181, email:
Lawrence.Vick@nrc.gov, or Richard
Jervey, Office of Nuclear Regulatory
Research, telephone: 301–251–7404,
email: Richard.Jervey@nrc.gov. Both are
staff of the U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001.
SUPPLEMENTARY INFORMATION:
I. Introduction
The NRC is issuing a revision to an
existing guide in the NRC’s ‘‘Regulatory
Guide’’ series. This series was
developed to describe and make
available to the public information such
as methods that are acceptable to the
NRC staff for implementing specific
parts of the agency’s regulations,
techniques that the staff uses in
evaluating specific problems or
postulated accidents, and data that the
staff needs in its review of applications
for permits and licenses.
Revision 4 of RG 1.134 was issued
with a temporary identification as draft
regulatory guide (DG), DG–1310. The
guidance is intended for use by nuclear
power plant license holders under part
50 of Title 10 of the Code of Federal
Regulations (10 CFR), ‘‘Domestic
Licensing of Production and Utilization
Facilities,’’ and 10 CFR Part 52,
‘‘Licenses, Certifications, and Approvals
for Nuclear Power Plants.’’ Licensees of
these facilities are required under 10
CFR 50.54, ‘‘Conditions of Licensees,’’
to use qualified licensed operators as
described in 10 CFR Part 55, ‘‘Operators’
Licenses.’’
Regulatory Guide 1.134, Revision 3,
‘‘Medical Evaluation of Licensed
Personnel for Nuclear Power Plants,’’
was issued in 1998 to identify that
consensus standard ANSI/ANS 3.4
(1996), ‘‘Medical Certification and
Monitoring of Personnel Requiring
Operator Licenses for Nuclear Power
Plants,’’ was a method acceptable to the
staff for complying with those portions
of the NRC’s regulations associated with
approval or acceptance of medical
examination certifications at nuclear
power plants.
The consensus standard ANSI/ANS
3.4 was issued in 2013 to provide
clarification and comprehensive
medical guidance to improve industry’s
consistent implementation of the
standard. This included clarification of
specific minimum requirements,
disqualifying conditions, conditional
restrictions, examination methods, and
monitoring methods for each medical
area. The 2013 issue also included
consideration of other industry medical
standards, including those of the U.S.
Department of Transportation and
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Federal Aviation Administration as well
as medical criteria that reflected
progressions in medical science
including updated terminology, current
medical practices, criteria for normality,
and risk assessments.
Regulatory Guide 1.134 was revised to
identify to licensees that ANSI/ANS
3.4–2013 is acceptable for their use. The
guide helps to ensure that medical
certifications (and related medical
evidence) used to meet the operator
licensing requirements of 10 CFR part
55 are sufficient with respect to (1) an
applicant’s or operator licensee’s
medical examination, as described in 10
CFR 55.21, ‘‘Medical Examination’’; (2)
a facility licensee’s medical
certification, as described in 10 CFR
55.23, ‘‘Certification’’; (3) an operator
licensee’s incapacitation because of
disability or illness, as described in 10
CFR 55.25, ‘‘Incapacitation Because of
Disability or Illness’’; and (4) a facility
licensee’s medical documentation, as
described in 10 CFR 55.27,
‘‘Documentation.’’
II. Additional Information
The DG–1310 was published in the
Federal Register on April 25, 2014 (79
FR 23017), for a 30-day public comment
period. The public comment period
closed on May 27, 2014. There were no
public comments received
III. Congressional Review Act
This RG is a rule as defined in the
Congressional Review Act (5 U.S.C.
801–808). However, the Office of
Management and Budget has not found
it to be a major rule as defined in the
Congressional Review Act.
IV. Backfitting and Issue Finality
Regulatory Guide 1.134, Revision 4,
provides updated guidance on the
methods acceptable to the NRC staff for
complying with the NRC’s regulations
associated with approval or acceptance
of the medical assessment of an
applicant for, or holder of, an operator
or senior operator license at a nuclear
power plant. The guide applies to
current and future applicants for, and
holders of, power reactor licenses under
10 CFR parts 50 and 52 and power
reactor operating licenses under 10 CFR
part 55. Issuance of RG 1.134, revision
4, does not constitute backfitting under
10 CFR part 50 and is not otherwise
inconsistent with the issue finality
provisions in 10 CFR Part 52. As
discussed in the ‘‘Implementation’’
section of RG 1.134, revision 4, the NRC
has no current intention to impose the
RG on current holders of 10 CFR part 50
operating licenses or 10 CFR part 52
combined licenses. Part 55 does not
E:\FR\FM\06OCN1.SGM
06OCN1
Federal Register / Vol. 79, No. 193 / Monday, October 6, 2014 / Notices
contain backfitting or issue finality
regulations, and power reactor operating
licensees are not protected by the
backfitting provisions in 10 CFR 50.109
or the 10 CFR part 52 issue finality
provisions because neither 10 CFR
50.109 nor 10 CFR part 52 applies to 10
CFR part 55 power reactor operating
licensees.
This RG could be applied to
applications for 10 CFR part 50
operating licenses, 10 CFR part 52
combined licenses, or 10 CFR part 55
operator licenses. Such action would
not constitute backfitting as defined in
10 CFR 50.109 or be otherwise
inconsistent with the applicable issue
finality provision in 10 CFR part 52,
inasmuch as such applicants are not
within the scope of entities protected by
10 CFR 50.109 or the relevant issue
finality provisions in 10 CFR part 52.
Dated at Rockville, Maryland, this 30th day
of September, 2014.
For the Nuclear Regulatory Commission.
Harriet Karagiannis,
Acting Chief, Regulatory Guidance and
Generic Issues Branch, Division of
Engineering, Office of Nuclear Regulatory
Research.
[FR Doc. 2014–23717 Filed 10–3–14; 8:45 am]
BILLING CODE 7590–01–P
POSTAL REGULATORY COMMISSION
[Docket Nos. MC2014–48 and CP2014–84;
Order No. 2200]
New Postal Product
Postal Regulatory Commission.
ACTION: Notice.
AGENCY:
The Commission is noticing a
recent Postal Service filing concerning
an addition of Priority Mail Contract 94
to the competitive product list. This
notice informs the public of the filing,
invites public comment, and takes other
administrative steps.
DATES: Comments are due: October 7,
2014.
ADDRESSES: Submit comments
electronically via the Commission’s
Filing Online system at https://
www.prc.gov. Those who cannot submit
comments electronically should contact
the person identified in the FOR FURTHER
INFORMATION CONTACT section by
telephone for advice on filing
alternatives.
FOR FURTHER INFORMATION CONTACT:
David A. Trissell, General Counsel, at
202–789–6820.
SUPPLEMENTARY INFORMATION:
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
Table of Contents
I. Introduction
VerDate Sep<11>2014
17:17 Oct 03, 2014
Jkt 235001
II. Notice of Commission Action
III. Ordering Paragraphs
I. Introduction
In accordance with 39 U.S.C. 3642
and 39 CFR 3020.30 et seq., the Postal
Service filed a formal request and
associated supporting information to
add Priority Mail Contract 94 to the
competitive product list.1
The Postal Service
contemporaneously filed a redacted
contract related to the proposed new
product under 39 U.S.C. 3632(b)(3) and
39 CFR 3015.5. Id. Attachment B.
To support its Request, the Postal
Service filed a copy of the contract, a
copy of the Governors’ Decision
authorizing the product, proposed
changes to the Mail Classification
Schedule, a Statement of Supporting
Justification, a certification of
compliance with 39 U.S.C. 3633(a), and
an application for non-public treatment
of certain materials. It also filed
supporting financial workpapers.
II. Notice of Commission Action
The Commission establishes Docket
Nos. MC2014–48 and CP2014–84 to
consider the Request pertaining to the
proposed Priority Mail Contract 94
product and the related contract,
respectively.
The Commission invites comments on
whether the Postal Service’s filings in
the captioned dockets are consistent
with the policies of 39 U.S.C. 3632,
3633, or 3642, 39 CFR part 3015, and 39
CFR part 3020, subpart B. Comments are
due no later than October 7, 2014. The
public portions of these filings can be
accessed via the Commission’s Web site
(https://www.prc.gov).
The Commission appoints James F.
Callow to serve as Public Representative
in these dockets.
60199
By the Commission.
Shoshana M. Grove,
Secretary.
[FR Doc. 2014–23669 Filed 10–3–14; 8:45 am]
BILLING CODE 7710–FW–P
POSTAL REGULATORY COMMISSION
[Docket Nos. MC2014–49 and CP2014–85;
Order No. 2199]
New Postal Product
Postal Regulatory Commission.
Notice.
AGENCY:
ACTION:
The Commission is noticing a
recent Postal Service filing concerning
an addition of Priority Mail Contract 95
to the competitive product list. This
notice informs the public of the filing,
invites public comment, and takes other
administrative steps.
DATES: Comments are due: October 7,
2014.
ADDRESSES: Submit comments
electronically via the Commission’s
Filing Online system at https://
www.prc.gov. Those who cannot submit
comments electronically should contact
the person identified in the FOR FURTHER
INFORMATION CONTACT section by
telephone for advice on filing
alternatives.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
David A. Trissell, General Counsel, at
202–789–6820.
SUPPLEMENTARY INFORMATION:
Table of Contents
I. Introduction
II. Notice of Commission Action
III. Ordering Paragraphs
III. Ordering Paragraphs
It is ordered:
1. The Commission establishes Docket
Nos. MC2014–48 and CP2014–84 to
consider the matters raised in each
docket.
2. Pursuant to 39 U.S.C. 505, James F.
Callow is appointed to serve as an
officer of the Commission to represent
the interests of the general public in
these proceedings (Public
Representative).
3. Comments are due no later than
October 7, 2014.
4. The Secretary shall arrange for
publication of this order in the Federal
Register.
I. Introduction
In accordance with 39 U.S.C. 3642
and 39 CFR 3020.30 et seq., the Postal
Service filed a formal request and
associated supporting information to
add Priority Mail Contract 95 to the
competitive product list.1
The Postal Service
contemporaneously filed a redacted
contract related to the proposed new
product under 39 U.S.C. 3632(b)(3) and
39 CFR 3015.5. Id. Attachment B.
To support its Request, the Postal
Service filed a copy of the contract, a
copy of the Governors’ Decision
authorizing the product, proposed
changes to the Mail Classification
Schedule, a Statement of Supporting
Justification, a certification of
1 Request of the United States Postal Service to
Add Priority Mail Contract 94 to Competitive
Product List and Notice of Filing (Under Seal) of
Unredacted Governors’ Decision, Contract, and
Supporting Data, September 29, 2014 (Request).
1 Request of the United States Postal Service to
Add Priority Mail Contract 95 to Competitive
Product List and Notice of Filing (Under Seal) of
Unredacted Governors’ Decision, Contract, and
Supporting Data, September 29, 2014 (Request).
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
E:\FR\FM\06OCN1.SGM
06OCN1
Agencies
[Federal Register Volume 79, Number 193 (Monday, October 6, 2014)]
[Notices]
[Pages 60197-60199]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23717]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2014-0093]
Medical Evaluation of Licensed Personnel for Nuclear Power Plants
AGENCY: Nuclear Regulatory Commission.
ACTION: Regulatory guide; issuance.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is issuing
revision 4 to Regulatory Guide (RG) 1.134, ``Medical Assessment of
Licensed
[[Page 60198]]
Operators or Applicants for Operator Licenses at Nuclear Power
Plants.'' The NRC is updating RG 1.134 based upon the regulatory
experience gained since the previous revision was issued and to endorse
the 2013 revision to the underlying consensus standard, American
National Standard Institute/American Nuclear Society (ANSI/ANS)
Standard 3.4, ``Medical Certification and Monitoring of Personnel
Requiring Licenses for Nuclear Power Plants.'' The guide helps to
ensure that medical certifications (and related medical evidence) are
sufficient to meet the NRC's nuclear power reactor operator licensing
requirements.
ADDRESSES: Please refer to Docket ID NRC-2014-0093 when contacting the
NRC about the availability of information regarding this document. You
may obtain publicly-available information related to this document
using any of the following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2014-0093. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-287-
3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section
of this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may access publicly available documents online in the NRC
Library at https://www.nrc.gov/reading-rm/adams.html. To begin the
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number
for each document referenced in this notice (if that document is
available in ADAMS) is provided the first time that a document is
referenced. Revision 4 of Regulatory Guide 1.134 is available in ADAMS
under Accession No. ML14189A385. The regulatory analysis may be found
in ADAMS under Accession No. ML13352A279.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
Regulatory guides are not copyrighted, and NRC approval is not
required to reproduce them.
FOR FURTHER INFORMATION CONTACT: Lawrence Vick, Office of Nuclear
Reactor Regulation, telephone: 301-415-3181, email:
Lawrence.Vick@nrc.gov, or Richard Jervey, Office of Nuclear Regulatory
Research, telephone: 301-251-7404, email: Richard.Jervey@nrc.gov. Both
are staff of the U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001.
SUPPLEMENTARY INFORMATION:
I. Introduction
The NRC is issuing a revision to an existing guide in the NRC's
``Regulatory Guide'' series. This series was developed to describe and
make available to the public information such as methods that are
acceptable to the NRC staff for implementing specific parts of the
agency's regulations, techniques that the staff uses in evaluating
specific problems or postulated accidents, and data that the staff
needs in its review of applications for permits and licenses.
Revision 4 of RG 1.134 was issued with a temporary identification
as draft regulatory guide (DG), DG-1310. The guidance is intended for
use by nuclear power plant license holders under part 50 of Title 10 of
the Code of Federal Regulations (10 CFR), ``Domestic Licensing of
Production and Utilization Facilities,'' and 10 CFR Part 52,
``Licenses, Certifications, and Approvals for Nuclear Power Plants.''
Licensees of these facilities are required under 10 CFR 50.54,
``Conditions of Licensees,'' to use qualified licensed operators as
described in 10 CFR Part 55, ``Operators' Licenses.''
Regulatory Guide 1.134, Revision 3, ``Medical Evaluation of
Licensed Personnel for Nuclear Power Plants,'' was issued in 1998 to
identify that consensus standard ANSI/ANS 3.4 (1996), ``Medical
Certification and Monitoring of Personnel Requiring Operator Licenses
for Nuclear Power Plants,'' was a method acceptable to the staff for
complying with those portions of the NRC's regulations associated with
approval or acceptance of medical examination certifications at nuclear
power plants.
The consensus standard ANSI/ANS 3.4 was issued in 2013 to provide
clarification and comprehensive medical guidance to improve industry's
consistent implementation of the standard. This included clarification
of specific minimum requirements, disqualifying conditions, conditional
restrictions, examination methods, and monitoring methods for each
medical area. The 2013 issue also included consideration of other
industry medical standards, including those of the U.S. Department of
Transportation and Federal Aviation Administration as well as medical
criteria that reflected progressions in medical science including
updated terminology, current medical practices, criteria for normality,
and risk assessments.
Regulatory Guide 1.134 was revised to identify to licensees that
ANSI/ANS 3.4-2013 is acceptable for their use. The guide helps to
ensure that medical certifications (and related medical evidence) used
to meet the operator licensing requirements of 10 CFR part 55 are
sufficient with respect to (1) an applicant's or operator licensee's
medical examination, as described in 10 CFR 55.21, ``Medical
Examination''; (2) a facility licensee's medical certification, as
described in 10 CFR 55.23, ``Certification''; (3) an operator
licensee's incapacitation because of disability or illness, as
described in 10 CFR 55.25, ``Incapacitation Because of Disability or
Illness''; and (4) a facility licensee's medical documentation, as
described in 10 CFR 55.27, ``Documentation.''
II. Additional Information
The DG-1310 was published in the Federal Register on April 25, 2014
(79 FR 23017), for a 30-day public comment period. The public comment
period closed on May 27, 2014. There were no public comments received
III. Congressional Review Act
This RG is a rule as defined in the Congressional Review Act (5
U.S.C. 801-808). However, the Office of Management and Budget has not
found it to be a major rule as defined in the Congressional Review Act.
IV. Backfitting and Issue Finality
Regulatory Guide 1.134, Revision 4, provides updated guidance on
the methods acceptable to the NRC staff for complying with the NRC's
regulations associated with approval or acceptance of the medical
assessment of an applicant for, or holder of, an operator or senior
operator license at a nuclear power plant. The guide applies to current
and future applicants for, and holders of, power reactor licenses under
10 CFR parts 50 and 52 and power reactor operating licenses under 10
CFR part 55. Issuance of RG 1.134, revision 4, does not constitute
backfitting under 10 CFR part 50 and is not otherwise inconsistent with
the issue finality provisions in 10 CFR Part 52. As discussed in the
``Implementation'' section of RG 1.134, revision 4, the NRC has no
current intention to impose the RG on current holders of 10 CFR part 50
operating licenses or 10 CFR part 52 combined licenses. Part 55 does
not
[[Page 60199]]
contain backfitting or issue finality regulations, and power reactor
operating licensees are not protected by the backfitting provisions in
10 CFR 50.109 or the 10 CFR part 52 issue finality provisions because
neither 10 CFR 50.109 nor 10 CFR part 52 applies to 10 CFR part 55
power reactor operating licensees.
This RG could be applied to applications for 10 CFR part 50
operating licenses, 10 CFR part 52 combined licenses, or 10 CFR part 55
operator licenses. Such action would not constitute backfitting as
defined in 10 CFR 50.109 or be otherwise inconsistent with the
applicable issue finality provision in 10 CFR part 52, inasmuch as such
applicants are not within the scope of entities protected by 10 CFR
50.109 or the relevant issue finality provisions in 10 CFR part 52.
Dated at Rockville, Maryland, this 30th day of September, 2014.
For the Nuclear Regulatory Commission.
Harriet Karagiannis,
Acting Chief, Regulatory Guidance and Generic Issues Branch, Division
of Engineering, Office of Nuclear Regulatory Research.
[FR Doc. 2014-23717 Filed 10-3-14; 8:45 am]
BILLING CODE 7590-01-P